Related Experiment Videos

Intravenous methylprednisolone pulse therapy for children with autoimmune hepatitis

Tsuyoshi Sogo1, Tomoo Fujisawa, Ayano Inui

  • 1Department of Pediatrics, Atami Hospital, International University of Health and Welfare, 13-1, Higashikaigancho, Atami City, Shizuoka 413-0012, Japan; Department of Pathology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.

Hepatology Research : the Official Journal of the Japan Society of Hepatology
|February 2, 2006
PubMed

Insights

Intravenous methylprednisolone pulse therapy (m-PSL) significantly speeds recovery in children with autoimmune hepatitis (AIH) compared to oral steroids. This approach appears safe and effective, potentially reducing side effects like growth issues.

Area of Science:

  • Pediatric Gastroenterology
  • Hepatology
  • Immunology

Background:

  • Autoimmune hepatitis (AIH) is a chronic liver disease requiring immunosuppressive therapy.
  • Corticosteroids are the mainstay of AIH treatment in children, but long-term use is associated with significant side effects.
  • Optimizing treatment strategies to improve efficacy and minimize adverse events is crucial.

Purpose of the Study:

  • To compare the efficacy and safety of intravenous methylprednisolone pulse therapy (m-PSL) versus conventional oral corticosteroid therapy in pediatric autoimmune hepatitis.
  • To evaluate the occurrence of corticosteroid-related side effects in children with AIH treated with different corticosteroid regimens.

Main Methods:

  • A retrospective study involving nine children diagnosed with autoimmune hepatitis.
  • Patients were divided into two groups: Group 1 received conventional oral prednisone therapy, while Group 2 received m-PSL as induction therapy followed by oral prednisone maintenance.
  • Efficacy was assessed by the time to normalization of alanine aminotransferase (ALT) levels, and safety was evaluated by monitoring corticosteroid-related side effects.

Main Results:

  • Children treated with m-PSL (Group 2) achieved normalization of ALT levels significantly faster (median 54 days) compared to those on oral prednisone alone (Group 1, median 285 days).
  • The most common side effects observed in both groups were obesity and growth retardation.
  • Group 1 showed a trend towards lower Z-scores and higher body mass index compared to Group 2, suggesting potentially fewer long-term growth-related adverse effects with m-PSL.

Conclusions:

  • Intravenous methylprednisolone pulse therapy (m-PSL) demonstrates potential as a safe and effective induction therapy for autoimmune hepatitis in children.
  • m-PSL may offer advantages in terms of faster biochemical remission and potentially a better side effect profile compared to conventional oral corticosteroid therapy.
  • Further prospective studies are warranted to establish optimal treatment protocols for AIH in pediatric populations.
Abstract

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...